UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For
the month of November 2026
Commission
File Number: 001-40678
EUDA
Health Holdings Limited
(Exact
Name of Registrant as Specified in its Charter)
60
Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979
(Address
of Principal Executive Offices and Zip Code)
Registrant’s
telephone number, including area code: +65 6327 1110
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form
40-F ☐
On
November 16, 2026, EUDA Health Holdings Limited, a company incorporated under the laws of the British Virgin Islands, issued the press
released furnished herewith as Exhibit 99.1.
Exhibits
| 99.1 |
|
Press Release dated November 16, 2026 |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, hereunto duly authorized.
| Dated:
November 16, 2026 |
|
|
| |
|
| |
EUDA
Health Holdings Limited |
| |
|
|
| |
By: |
/s/
Alfred Lim |
| |
Name: |
Alfred
Lim |
| |
Title: |
Chief
Executive Officer |
Exhibit
99.1
EUDA
Health Subsidiary Melana International Wins Golden Bull Award 2026 Singapore
SINGAPORE,
Nov. 16, 2026 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”),
a Singapore-based distributor of third-party wellness and non-invasive healthcare products and services in Singapore, Malaysia and China,
as well as property management services in Singapore, today announced that its subsidiary, Melana International Pte. Ltd. (“Melana”),
was recognised as one of the winners of the Golden Bull Award 2026 Singapore, organised by Business Media International.
The
Golden Bull Award recognises outstanding small and medium-sized enterprises across Singapore, Malaysia, Taiwan and China. Since 2003,
the programme has evaluated companies based on financial performance and business resilience. The awards are officially audited by Baker
Tilly Singapore.
Founded
in 2000, Melana has a track record of more than 25 years in Singapore’s property management sector, managing a diverse portfolio
spanning high-end residential estates, commercial buildings, high-tech industrial parks, shopping malls and mixed-use developments. Melana
currently manages 33 properties across Singapore which include 5,488 residential and commercial units.
This
award highlights Melana’s established capabilities in property and strata management and the long-term client relationships behind
its portfolio. Of the 33 properties under its management, 12 have been with Melana for at least 10 years, including four for more than
15 years, and five were added in 2026.
This
Golden Bull Award adds to a series of accolades received by Melana in 2026, including the SME100 Awards 2026, Sustainable Brand Awards
2026, Business Trust Award 2026, Singapore SME Leadership & Achievement Awards 2026, and Singapore Trusted Quality Brand 2026.
About
EUDA Health Holdings Limited
EUDA
Health Holdings Limited (NASDAQ: EUDA) is a Singapore-based distributor of third-party wellness and non-invasive healthcare products
and services in Singapore, Malaysia and China. The Company aims to become a market leading distributor of non-invasive and preventive
healthcare, with a strategic focus on the fast-growing longevity sector. Our mission is to address the evolving healthcare needs of over
1.8 billion people across the region which is experiencing significant demographic shifts as more than 30% of the population ages rapidly.
By facilitating access to innovative, accessible, and science-backed third-party wellness and non-invasive healthcare products and services,
EUDA is positioned to help with the transformation of regional healthcare from reactive medical treatment to proactive, longevity-focused
care. EUDA also runs a Singapore-based property management business.
Forward-Looking
Statements
Certain
statements in this press release that are not historical facts constitute “forward-looking statements” within the meaning
of Section 21E of the Securities Exchange Act of 1934, as amended. Any statements that refer to expectations or other characterizations
of future events, circumstances or results are forward-looking statements. Such forward-looking statements involve known and unknown
risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially
different from the results, performance or achievements expressed or implied by such forward-looking statements. The factors may include,
but not be limited to, factors related to the Company’s anticipated growth strategies, future business development, ability to
launch new products and services, enter into distribution agreements or strategic alliances with third parties, expand to other related
industries or markets, and other information contained in the Company’s annual reports on Form 20-F, and detailed from time to
time in the filings and future filings with the United States Securities and Exchange Commission. The views expressed are those of management
and are based on currently available information. Estimates and projections contained herein have been prepared by management and involve
significant elements of subjective judgment and analysis and are based on certain assumptions. No representation nor warranty, expressed
or implied, is made as to the accuracy or completeness of the information contained in this document, and nothing contained herein is,
or shall be relied upon, as a promise or representation, whether as to the past or the future. You are cautioned not to place undue reliance
on these forward-looking statements. The Company undertakes no obligation to update these statements for revisions or changes after the
date of this press release, except as required by law.
This
press release is intended solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an
offer to buy the Company’s securities. This press release is based upon information available to the public, as well as other information
from sources which management believes to be reliable, but is not guaranteed by the Company as being accurate nor does it purport to
be complete. Opinions expressed herein are those of management as of the date of publication and are subject to change without notice.
Christensen
Advisory
Christian
Arnell
Phone:
+ 852 2117 0861
Email:
christian.arnell@christensencomms.com